{"id":294976,"date":"2020-04-19T13:21:23","date_gmt":"2020-04-19T12:21:23","guid":{"rendered":"http:\/\/kapitalis.com\/tunisie\/?p=294976"},"modified":"2020-04-19T20:47:24","modified_gmt":"2020-04-19T19:47:24","slug":"covid-19-essai-recovery-et-antiviral-du-pauvre","status":"publish","type":"post","link":"https:\/\/kapitalis.com\/tunisie\/2020\/04\/19\/covid-19-essai-recovery-et-antiviral-du-pauvre\/","title":{"rendered":"Covid-19 : Essai Discovery et antiviral du pauvre"},"content":{"rendered":"\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"http:\/\/kapitalis.com\/tunisie\/wp-content\/uploads\/2020\/04\/Coronavirus.jpg\" alt=\"\" class=\"wp-image-294977\"\/><\/figure>\n\n\n\n<p><strong><em>Le plus grand essai clinique th\u00e9rapeutique incluant pr\u00e8s de 5000 patients issus de 165 h\u00f4pitaux pendant un mois, appel\u00e9 Recovery , est actuellement r\u00e9alis\u00e9 au Royaume-Uni (bilan du 18 avril 2020 : 114 217 cas, 15 464 morts) afin de tester la r\u00e9ponse des patients atteints de Covid-19 \u00e0 diff\u00e9rents types de traitements.<\/em><\/strong><\/p>\n\n\n\n<p>Par <strong>Dr Mounir Hanablia<\/strong> *<\/p>\n\n\n\n<!--more-->\n\n\n\n<p>Les m\u00e9dicaments test\u00e9s sont l\u2019Hydroxychloroquine et Azithromycine, s\u00e9par\u00e9ment puis ensemble, une association d\u2019antiviraux dont l\u2019efficacit\u00e9 a \u00e9t\u00e9 av\u00e9r\u00e9e au cours de l\u2019Ebola liponavir-ritonavir (Kaletra), des anti interleukines 6 dont pour s\u2019opposer aux cytokines responsables de l\u2019hyper r\u00e9activit\u00e9 inflammatoire (tocilizumab), des anticorps issus du plasma sanguin de malades contamin\u00e9s.<\/p>\n\n\n\n<p>Le Remdesivir n\u2019a pas pu \u00eatre test\u00e9, l\u2019\u00e9tant d\u00e9j\u00e0 en Chine et aux Etats-Unis.<\/p>\n\n\n\n<p>Les patients b\u00e9n\u00e9ficiaires de ces traitements sont compar\u00e9s \u00e0 des groupes t\u00e9moins placebo.<\/p>\n\n\n\n<p>L\u2019int\u00e9r\u00eat de cet essai est d\u2019abord d\u2019essayer de chercher des certitudes scientifiques clairement \u00e9tablies, alors que jusqu\u2019\u00e0 pr\u00e9sent, ce sont seules les impressions de certaines sommit\u00e9s scientifiques qui ont influenc\u00e9 les choix et les discours politiques, tels ceux des pr\u00e9sidents Trump et Macron (Pr Didier Raoult) par rapport \u00e0 l\u2019usage de l\u2019hydroxychloroquine.<\/p>\n\n\n\n<p>Ce qui est remarquable dans un tel essai clinique c\u2019est d\u2019abord la vitesse avec laquelle il est r\u00e9alis\u00e9, alors qu\u2019habituellement cela prendrait des ann\u00e9es dans des recherches semblables. Ensuite, c\u2019est le nombre de m\u00e9decins impliqu\u00e9s, contrairement aux habitudes prises d\u2019en confier la r\u00e9alisation \u00e0 un petit nombre d\u2019initi\u00e9s dans des endroits recul\u00e9s des h\u00f4pitaux, et dont personne ne parle. <\/p>\n\n\n\n<p>C\u2019est un peu ce qui se passe en Tunisie depuis toujours, o\u00f9 les petites querelles de chapelles entre les services ont souvent la vie dure, et la situation actuelle que traverse le pays ne semble pas imposer de d\u00e9rogations sp\u00e9ciales aux r\u00e8gles \u00e9tablies issues de l\u2019\u00e9cole fran\u00e7aise, des petits secrets jalousement gard\u00e9s.<\/p>\n\n\n\n<p>On n\u2019a malheureusement pas encore entendu parler de r\u00e9sultats pr\u00e9liminaires d\u2019essais th\u00e9rapeutiques, le faible nombre de cas \u00e9tablis et hospitalis\u00e9s de Covid-19, pour le moment, interdisant il est vrai de tirer des conclusions probantes. <\/p>\n\n\n\n<p>Seul le s\u00e9quen\u00e7age de l\u2019ARN viral a pour le moment constitu\u00e9 un succ\u00e8s ind\u00e9niable de la recherche tunisienne, mais l\u2019initiation d\u2019essais cliniques, sans pour autant indiquer les drogues utilis\u00e9es afin de ne pas provoquer l\u2019habituelle r\u00e9action pr\u00e9visible du public de les d\u00e9valiser dans les pharmacies, ne serait pas une mauvaise chose aux yeux d\u2019une opinion publique inqui\u00e8te\u2026<\/p>\n\n\n\n<p>Quoi qu\u2019il en soit, les r\u00e9sultats de cet essai clinique qui fera date dans l\u2019histoire de la recherche m\u00e9dicale, tellement il est soumis \u00e0 des besoins imp\u00e9rieux, seront sans doute disponible en principe au mois de juin afin, pour nous, de savoir d\u00e9finitivement si l\u2019Hydroxychloroquine, pourra ou non \u00eatre consid\u00e9r\u00e9e, dans l\u2019actuelle pand\u00e9mie , comme le traitement du pauvre ou du radin. <\/p>\n\n\n\n<p>* <em>Cardiologue, Gammarth, La Marsa.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le plus grand essai clinique th\u00e9rapeutique incluant pr\u00e8s de 5000 patients issus de 165 h\u00f4pitaux pendant un mois, appel\u00e9 Recovery , est actuellement r\u00e9alis\u00e9 au Royaume-Uni (bilan du 18 avril 2020 : 114 217 cas, 15 464 morts) afin de tester la r\u00e9ponse des patients atteints de Covid-19 \u00e0 diff\u00e9rents types de traitements. Par Dr&#8230;<\/p>\n","protected":false},"author":8,"featured_media":294977,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[992,998,1000,2433],"tags":[76715,75291,77986,76782,77987,77988],"class_list":["post-294976","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-a-la-une","category-societe","category-tribune","category-tunisie","tag-azithromycine","tag-covid-19","tag-essai-recovery","tag-hydroxychloroquine","tag-remdesivir","tag-sequencage-de-larn-viral"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Covid-19 : Essai Discovery et antiviral du pauvre - Kapitalis<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/kapitalis.com\/tunisie\/2020\/04\/19\/covid-19-essai-recovery-et-antiviral-du-pauvre\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Covid-19 : Essai Discovery et antiviral du pauvre - Kapitalis\" \/>\n<meta property=\"og:description\" content=\"Le plus grand essai clinique th\u00e9rapeutique incluant pr\u00e8s de 5000 patients issus de 165 h\u00f4pitaux pendant un mois, appel\u00e9 Recovery , est actuellement r\u00e9alis\u00e9 au Royaume-Uni (bilan du 18 avril 2020 : 114 217 cas, 15 464 morts) afin de tester la r\u00e9ponse des patients atteints de Covid-19 \u00e0 diff\u00e9rents types de traitements. Par Dr...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/kapitalis.com\/tunisie\/2020\/04\/19\/covid-19-essai-recovery-et-antiviral-du-pauvre\/\" \/>\n<meta property=\"og:site_name\" content=\"Kapitalis\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/KapitalisInfo\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-04-19T12:21:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-04-19T19:47:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/kapitalis.com\/tunisie\/wp-content\/uploads\/2022\/05\/kapitalis-logo-fb.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"webmaster kapitalis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@KapitalisInfo\" \/>\n<meta name=\"twitter:site\" content=\"@KapitalisInfo\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"webmaster kapitalis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/kapitalis.com\/tunisie\/2020\/04\/19\/covid-19-essai-recovery-et-antiviral-du-pauvre\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/kapitalis.com\/tunisie\/2020\/04\/19\/covid-19-essai-recovery-et-antiviral-du-pauvre\/\"},\"author\":{\"name\":\"webmaster kapitalis\",\"@id\":\"https:\/\/kapitalis.com\/tunisie\/#\/schema\/person\/d71f33a9ca44f7bad4698210b480c8e9\"},\"headline\":\"Covid-19 : Essai Discovery et antiviral du pauvre\",\"datePublished\":\"2020-04-19T12:21:23+00:00\",\"dateModified\":\"2020-04-19T19:47:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/kapitalis.com\/tunisie\/2020\/04\/19\/covid-19-essai-recovery-et-antiviral-du-pauvre\/\"},\"wordCount\":531,\"commentCount\":3,\"publisher\":{\"@id\":\"https:\/\/kapitalis.com\/tunisie\/#organization\"},\"image\":{\"@id\":\"https:\/\/kapitalis.com\/tunisie\/2020\/04\/19\/covid-19-essai-recovery-et-antiviral-du-pauvre\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"azithromycine\",\"Covid-19\",\"essai Recovery\",\"hydroxychloroquine\",\"Remdesivir\",\"s\u00e9quen\u00e7age de l\u2019ARN viral\"],\"articleSection\":[\"A LA UNE\",\"SOCIETE\",\"TRIBUNE\",\"Tunisie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/kapitalis.com\/tunisie\/2020\/04\/19\/covid-19-essai-recovery-et-antiviral-du-pauvre\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/kapitalis.com\/tunisie\/2020\/04\/19\/covid-19-essai-recovery-et-antiviral-du-pauvre\/\",\"url\":\"https:\/\/kapitalis.com\/tunisie\/2020\/04\/19\/covid-19-essai-recovery-et-antiviral-du-pauvre\/\",\"name\":\"Covid-19 : Essai Discovery et antiviral du pauvre - Kapitalis\",\"isPartOf\":{\"@id\":\"https:\/\/kapitalis.com\/tunisie\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/kapitalis.com\/tunisie\/2020\/04\/19\/covid-19-essai-recovery-et-antiviral-du-pauvre\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/kapitalis.com\/tunisie\/2020\/04\/19\/covid-19-essai-recovery-et-antiviral-du-pauvre\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2020-04-19T12:21:23+00:00\",\"dateModified\":\"2020-04-19T19:47:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/kapitalis.com\/tunisie\/2020\/04\/19\/covid-19-essai-recovery-et-antiviral-du-pauvre\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/kapitalis.com\/tunisie\/2020\/04\/19\/covid-19-essai-recovery-et-antiviral-du-pauvre\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/kapitalis.com\/tunisie\/2020\/04\/19\/covid-19-essai-recovery-et-antiviral-du-pauvre\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/kapitalis.com\/tunisie\/2020\/04\/19\/covid-19-essai-recovery-et-antiviral-du-pauvre\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/kapitalis.com\/tunisie\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Covid-19 : Essai Discovery et antiviral du pauvre\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/kapitalis.com\/tunisie\/#website\",\"url\":\"https:\/\/kapitalis.com\/tunisie\/\",\"name\":\"Kapitalis\",\"description\":\"L&#039;actualit\u00e9 en Tunisie et dans le monde\",\"publisher\":{\"@id\":\"https:\/\/kapitalis.com\/tunisie\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/kapitalis.com\/tunisie\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/kapitalis.com\/tunisie\/#organization\",\"name\":\"Kapitalis\",\"url\":\"https:\/\/kapitalis.com\/tunisie\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/kapitalis.com\/tunisie\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/kapitalis.com\/tunisie\/wp-content\/uploads\/2022\/05\/Kapitalis-big-size.png\",\"contentUrl\":\"https:\/\/kapitalis.com\/tunisie\/wp-content\/uploads\/2022\/05\/Kapitalis-big-size.png\",\"width\":5000,\"height\":1500,\"caption\":\"Kapitalis\"},\"image\":{\"@id\":\"https:\/\/kapitalis.com\/tunisie\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/KapitalisInfo\/\",\"https:\/\/x.com\/KapitalisInfo\",\"https:\/\/www.youtube.com\/channel\/UC-yDYrHyfFBWWZaOw3FPg9Q\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/kapitalis.com\/tunisie\/#\/schema\/person\/d71f33a9ca44f7bad4698210b480c8e9\",\"name\":\"webmaster kapitalis\",\"url\":\"https:\/\/kapitalis.com\/tunisie\/author\/webmaster-kapitalis\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Covid-19 : Essai Discovery et antiviral du pauvre - Kapitalis","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kapitalis.com\/tunisie\/2020\/04\/19\/covid-19-essai-recovery-et-antiviral-du-pauvre\/","og_locale":"fr_FR","og_type":"article","og_title":"Covid-19 : Essai Discovery et antiviral du pauvre - Kapitalis","og_description":"Le plus grand essai clinique th\u00e9rapeutique incluant pr\u00e8s de 5000 patients issus de 165 h\u00f4pitaux pendant un mois, appel\u00e9 Recovery , est actuellement r\u00e9alis\u00e9 au Royaume-Uni (bilan du 18 avril 2020 : 114 217 cas, 15 464 morts) afin de tester la r\u00e9ponse des patients atteints de Covid-19 \u00e0 diff\u00e9rents types de traitements. Par Dr...","og_url":"https:\/\/kapitalis.com\/tunisie\/2020\/04\/19\/covid-19-essai-recovery-et-antiviral-du-pauvre\/","og_site_name":"Kapitalis","article_publisher":"https:\/\/www.facebook.com\/KapitalisInfo\/","article_published_time":"2020-04-19T12:21:23+00:00","article_modified_time":"2020-04-19T19:47:24+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/kapitalis.com\/tunisie\/wp-content\/uploads\/2022\/05\/kapitalis-logo-fb.png","type":"image\/png"}],"author":"webmaster kapitalis","twitter_card":"summary_large_image","twitter_creator":"@KapitalisInfo","twitter_site":"@KapitalisInfo","twitter_misc":{"\u00c9crit par":"webmaster kapitalis","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/kapitalis.com\/tunisie\/2020\/04\/19\/covid-19-essai-recovery-et-antiviral-du-pauvre\/#article","isPartOf":{"@id":"https:\/\/kapitalis.com\/tunisie\/2020\/04\/19\/covid-19-essai-recovery-et-antiviral-du-pauvre\/"},"author":{"name":"webmaster kapitalis","@id":"https:\/\/kapitalis.com\/tunisie\/#\/schema\/person\/d71f33a9ca44f7bad4698210b480c8e9"},"headline":"Covid-19 : Essai Discovery et antiviral du pauvre","datePublished":"2020-04-19T12:21:23+00:00","dateModified":"2020-04-19T19:47:24+00:00","mainEntityOfPage":{"@id":"https:\/\/kapitalis.com\/tunisie\/2020\/04\/19\/covid-19-essai-recovery-et-antiviral-du-pauvre\/"},"wordCount":531,"commentCount":3,"publisher":{"@id":"https:\/\/kapitalis.com\/tunisie\/#organization"},"image":{"@id":"https:\/\/kapitalis.com\/tunisie\/2020\/04\/19\/covid-19-essai-recovery-et-antiviral-du-pauvre\/#primaryimage"},"thumbnailUrl":"","keywords":["azithromycine","Covid-19","essai Recovery","hydroxychloroquine","Remdesivir","s\u00e9quen\u00e7age de l\u2019ARN viral"],"articleSection":["A LA UNE","SOCIETE","TRIBUNE","Tunisie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/kapitalis.com\/tunisie\/2020\/04\/19\/covid-19-essai-recovery-et-antiviral-du-pauvre\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/kapitalis.com\/tunisie\/2020\/04\/19\/covid-19-essai-recovery-et-antiviral-du-pauvre\/","url":"https:\/\/kapitalis.com\/tunisie\/2020\/04\/19\/covid-19-essai-recovery-et-antiviral-du-pauvre\/","name":"Covid-19 : Essai Discovery et antiviral du pauvre - Kapitalis","isPartOf":{"@id":"https:\/\/kapitalis.com\/tunisie\/#website"},"primaryImageOfPage":{"@id":"https:\/\/kapitalis.com\/tunisie\/2020\/04\/19\/covid-19-essai-recovery-et-antiviral-du-pauvre\/#primaryimage"},"image":{"@id":"https:\/\/kapitalis.com\/tunisie\/2020\/04\/19\/covid-19-essai-recovery-et-antiviral-du-pauvre\/#primaryimage"},"thumbnailUrl":"","datePublished":"2020-04-19T12:21:23+00:00","dateModified":"2020-04-19T19:47:24+00:00","breadcrumb":{"@id":"https:\/\/kapitalis.com\/tunisie\/2020\/04\/19\/covid-19-essai-recovery-et-antiviral-du-pauvre\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kapitalis.com\/tunisie\/2020\/04\/19\/covid-19-essai-recovery-et-antiviral-du-pauvre\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/kapitalis.com\/tunisie\/2020\/04\/19\/covid-19-essai-recovery-et-antiviral-du-pauvre\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/kapitalis.com\/tunisie\/2020\/04\/19\/covid-19-essai-recovery-et-antiviral-du-pauvre\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/kapitalis.com\/tunisie\/"},{"@type":"ListItem","position":2,"name":"Covid-19 : Essai Discovery et antiviral du pauvre"}]},{"@type":"WebSite","@id":"https:\/\/kapitalis.com\/tunisie\/#website","url":"https:\/\/kapitalis.com\/tunisie\/","name":"Kapitalis","description":"L&#039;actualit\u00e9 en Tunisie et dans le monde","publisher":{"@id":"https:\/\/kapitalis.com\/tunisie\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kapitalis.com\/tunisie\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/kapitalis.com\/tunisie\/#organization","name":"Kapitalis","url":"https:\/\/kapitalis.com\/tunisie\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/kapitalis.com\/tunisie\/#\/schema\/logo\/image\/","url":"https:\/\/kapitalis.com\/tunisie\/wp-content\/uploads\/2022\/05\/Kapitalis-big-size.png","contentUrl":"https:\/\/kapitalis.com\/tunisie\/wp-content\/uploads\/2022\/05\/Kapitalis-big-size.png","width":5000,"height":1500,"caption":"Kapitalis"},"image":{"@id":"https:\/\/kapitalis.com\/tunisie\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/KapitalisInfo\/","https:\/\/x.com\/KapitalisInfo","https:\/\/www.youtube.com\/channel\/UC-yDYrHyfFBWWZaOw3FPg9Q"]},{"@type":"Person","@id":"https:\/\/kapitalis.com\/tunisie\/#\/schema\/person\/d71f33a9ca44f7bad4698210b480c8e9","name":"webmaster kapitalis","url":"https:\/\/kapitalis.com\/tunisie\/author\/webmaster-kapitalis\/"}]}},"_links":{"self":[{"href":"https:\/\/kapitalis.com\/tunisie\/wp-json\/wp\/v2\/posts\/294976","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kapitalis.com\/tunisie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kapitalis.com\/tunisie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kapitalis.com\/tunisie\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/kapitalis.com\/tunisie\/wp-json\/wp\/v2\/comments?post=294976"}],"version-history":[{"count":0,"href":"https:\/\/kapitalis.com\/tunisie\/wp-json\/wp\/v2\/posts\/294976\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kapitalis.com\/tunisie\/wp-json\/wp\/v2\/media\/294977"}],"wp:attachment":[{"href":"https:\/\/kapitalis.com\/tunisie\/wp-json\/wp\/v2\/media?parent=294976"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kapitalis.com\/tunisie\/wp-json\/wp\/v2\/categories?post=294976"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kapitalis.com\/tunisie\/wp-json\/wp\/v2\/tags?post=294976"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}